Labcorp Holdings Inc’s filing revealed that its Director ANDERSON KERRII B unloaded Company’s shares for reported $0.13 million on Mar 05 ’25. In the deal valued at $255.63 per share,500 shares were sold. As a result of this transaction, ANDERSON KERRII B now holds 13,166 shares worth roughly $3.33 million.
Then, KERRII B ANDERSON bought 500 shares, generating $127,817 in total proceeds.
Before that, Schroeder Mark S sold 5,339 shares. Labcorp Holdings Inc shares valued at $1,330,639 were divested by the EVP, Pres Diagnostics & COO at a price of $249.23 per share. As a result of the transaction, Schroeder Mark S now holds 4,960 shares, worth roughly $1.26 million.
Citigroup upgraded its Labcorp Holdings Inc [LH] rating to a Buy from a a Neutral in a research note published on March 04, 2025; the price target was increased to $300 from $250. A number of analysts have revised their coverage, including Evercore ISI’s analysts, who increased its forecast for the stock in early January from “an In-line” to “an Outperform”. HSBC Securities revised its rating on October 30, 2024. It rated LH as “a Buy” which previously was an “a Hold”.
Price Performance Review of LH
On Friday, Labcorp Holdings Inc [NYSE:LH] saw its stock fall -0.41% to $253.03. Over the last five days, the stock has gained 0.79%. Labcorp Holdings Inc shares have risen nearly 10.34% since the year began. Nevertheless, the stocks have risen 17.06% over the past one year. While a 52-week high of $258.59 was reached on 03/05/25, a 52-week low of $191.97 was recorded on 01/03/25. SMA at 50 days reached $243.06, while 200 days put it at $225.65.
Levels Of Support And Resistance For LH Stock
The 24-hour chart illustrates a support level at 251.51, which if violated will result in even more drops to 249.99. On the upside, there is a resistance level at 255.34. A further resistance level may holdings at 257.65. The Relative Strength Index (RSI) on the 14-day chart is 58.10, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 2.33, which suggests price will go up in the next trading period. Percent R suggests that price movement has been low at 38.42%. Stochastics %K at 68.14% indicates the stock is a holding.
The most recent change occurred on October 01, 2024 when Piper Sandler began covering the stock and recommended ‘”a Neutral”‘ rating along with a $235 price target.
